Modelling the cost-effectiveness of cervical cancer screening with HPV self-sampling and molecular triage for women aged 60–69 years

Background Since 2022, self-sampling has been recommended in Sweden’s cervical screening program. Despite still being used primarily for long-term non-attendees, its expected increase in use raises interest in molecular triage methods applicable to self-collected samples. Postmenopausal women face s...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Discover. Oncology Ročník 16; číslo 1; s. 805 - 12
Hlavní autoři:	Fridljung, Jasmine, Bergengren, Lovisa, Ryen, Linda, Lillsunde Larsson, Gabriella
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New York Springer US 18.05.2025 Springer Nature B.V Springer
Témata:	Age groups Cancer Research Cellular biology Cervical cancer Cervical screening Cost analysis Cost-effectiveness DNA methylation Economic evaluation Genotyping HPV HSIL Human papillomavirus Internal Medicine Medical screening Medicine Medicine & Public Health Methylation Molecular Medicine Oncology Radiotherapy Self-sampling Surgical Oncology Vagina Womens health Sweden Self-sampling Genotyping Economic evaluation Cervical screening Methylation Cost-effectiveness HPV HSIL
ISSN:	2730-6011, 2730-6011
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!